Drugs Expert Witnesses
Pharmaceutical products move through a long chain of developers, contract manufacturers, wholesalers, pharmacy benefit managers, compounders, and providers, and disputes can arise at every link. Branded companies sue generic manufacturers over launches that allegedly violated patent settlement terms, sponsors pursue contract manufacturers whose undisclosed quality deviations triggered regulatory warning letters, and hospital systems challenge wholesalers and manufacturers that failed to honor supply commitments during shortages. Other matters involve formulary decisions shaped by rebate arrangements, counterfeit product entering the distribution system, or reformulated drugs that may fall outside a license's royalty-bearing scope. The underlying question is usually whether a party's conduct met the scientific, manufacturing, regulatory, or contractual standard that governs how drugs are made, sold, and paid for.
Drug experts evaluate that standard against the documentary record, reviewing batch records, stability and sterility data, allocation data, rebate terms, or formulation chemistry depending on where the dispute arose. A current good manufacturing practice review can establish whether deviations predated a sponsor's release decision, while a formulation comparison can show whether a reformulated product still practices the licensed technology. The same discipline applies to supply and distribution claims, where allocation and capacity analysis can reveal whether shortfalls reflected genuine constraints or diversion to more profitable accounts. These findings anchor liability and causation, give damages experts a reliable factual foundation, and allow counsel to challenge opposing opinions that misapply regulatory requirements or industry practice.
Because drug disputes can turn on chemistry, pharmacology, regulation, or reimbursement, selecting an expert starts with identifying which of those disciplines the evidence actually implicates. Our network includes FDA regulatory specialists who have published on enforcement procedures, warning letters, and compliance programs, medicinal and synthetic organic chemists with deep experience in pharmaceutical compounds, and clinical pharmacologists who have testified on medication effects and professional standards. It also includes a cardiovascular researcher who founded a biotechnology company and took it public, along with a reimbursement specialist who has testified on coverage disputes and False Claims Act matters. Round Table Group draws on more than 75,000 expert searches for litigators to match that experience to the specific issues in your case. Let us help you find the right drugs expert by calling us at (202) 908-4500.